The clinical value of serum CA125 levels in ovarian cancer patients receiving platinum therapy

This publication has 17 references indexed in Scilit:

• Evaluation of an Immunoradiometric Assay for the Detection of an Ovarian Tumour Marker, CA125, in Serum
  Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1986
• Elevation of serum CA 125 prior to diagnosis of an epithelial ovarian carcinoma
  Gynecologic Oncology, 1985
• Ovarian cancer antigen CA125: a prospective clinical assessment of its role as a tumour marker
  British Journal of Cancer, 1984
• RANDOMISED TRIAL COMPARING TWO COMBINATION CHEMOTHERAPY REGIMENS (HEXA-CAF VS CHAP-5) IN ADVANCED OVARIAN CARCINOMA
  The Lancet, 1984
• Serum haptoglobin and α1-acid glycoprotein as indicators of the effectiveness of cis-diamminedichloroplatinum (CDDP) in ovarian cancer patients—a preliminary report
  European Journal of Cancer and Clinical Oncology, 1984
• A Radioimmunoassay Using a Monoclonal Antibody to Monitor the Course of Epithelial Ovarian Cancer
  New England Journal of Medicine, 1983
• Biochemical aids in the monitoring of patients with ovarian cancer
  Gynecologic Oncology, 1983
• Biochemical Markers in Ovarian Cancer: Possibilities and Limitations
  Annals of Clinical Biochemistry: International Journal of Laboratory Medicine, 1982
• Reactivity of a monoclonal antibody with human ovarian carcinoma.
  Journal of Clinical Investigation, 1981
• Epithelial Carcinoma of the Ovary: Current Strategies
  Annals of Internal Medicine, 1981